Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iontophoretic Terbinafine Gel for Onychomycosis
NCT01080079Phase 2Completed
- Sponsor
- Nitric BioTherapeutics
- Start
- May 2010
- Primary completion
- Nov 2011
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, single-blind trial of Terbinafine subungual gel in onychomycosis (6 arms), sponsored by Nitric BioTherapeutics. Primary endpoint: Clinical and Microbiological Improvement in nails vs placebo at 11 months. Started May 2010; status: completed.
02
Drugs
Terbinafine subungual gel
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT01080079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080079.